BONNIE MASK: Open Payments
NPI 1518964972 · NEW ALBANY, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$354 in 20 payments from 8 companies in 2025. Trend: 2023 $416 · 2024 $484 · 2025 $354
Food & beverage: $354
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 6 | $112 |
| Amgen Inc. | 4 | $63 |
| Novo Nordisk Inc | 3 | $48 |
| ABBVIE INC. | 2 | $41 |
| AstraZeneca Pharmaceuticals LP | 2 | $33 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $25 |
| PFIZER INC. | 1 | $17 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $15 |
Products named: MOUNJARO, EVENITY, VRAYLAR, Ozempic, TRINTELLIX, FARXIGA, ELIQUIS, CAPLYTA.
Industry payments across MS — which companies pay providers there.
